Contraindication of live vaccines in immunocompromised patients: an estimate of the number of affected people in the USA and the UK

Contraindication of live vaccines in immunocompromised patients: an estimate of the number of affected people in the USA and the UK

Highlights • Live attenuated vaccines are usually contraindicated for individuals with immunocompromising (IC) conditions. • An estimate of the size of the IC population is vital to make vaccine decisions. • Key IC conditions were obtained from vaccination guidelines and recommendations. • Approxima...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Public health (London) 2017-01, Vol.142, p.46-49
Hauptverfasser: Varghese, L, Curran, D, Bunge, E, Vroling, H, van Kessel, F, Guignard, A, Casabona, G, Olivieri, A
Format: Artikel
Sprache:eng
Schlagworte:
Adults
At risk populations
Critical incidents
Fever
Health risks
Herpes zoster
Immunocompromised hosts
Infectious Disease
Infectious diseases
Internal Medicine
Measles
Mumps
Risk assessment
Shingles
Vaccines
Varicella
Vector-borne diseases
Yellow fever
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Highlights • Live attenuated vaccines are usually contraindicated for individuals with immunocompromising (IC) conditions. • An estimate of the size of the IC population is vital to make vaccine decisions. • Key IC conditions were obtained from vaccination guidelines and recommendations. • Approximately 3% of the total population of adults in the USA and UK had an IC condition.
ISSN:0033-3506
1476-5616
DOI:10.1016/j.puhe.2016.10.013